AstraZeneca vaccine: New cases of rare thrombosis in three countries

There have been reports of rare thrombosis cases in people who have been given the AstraZeneca Covid vaccine.

In particular, 30 such cases have been reported in the United Kingdom since receiving the vaccine, the regulator said on Thursday.

The Food and Drug Administration (MHRA) said there were no reports of thrombosis after receiving the Pfizer / BioNTech vaccine.

According to MHRA officials, the agency continues to believe that the potential benefits of the AstraZeneca vaccine, developed by the Anglo-Swedish pharmaceutical industry in collaboration with the University of Oxford, far outweigh the potential risks of thrombosis in vaccinated people.

It is noted that some countries have decided to limit the use of the AstraZeneca vaccine, while others have resumed immunization campaigns, while the search for rare – but sometimes very serious – cases of thrombosis continues.

On March 18, the MHRA reported five cases of brain thrombosis out of a total of 11 million doses administered.

Yesterday he spoke of 22 cases of brain thrombosis and eight cases of other thrombosis out of a total of 18.1 million doses that have been administered.

In addition, in the Netherlands, the Lareb Center for the Study of Side Effects has received five reports of extensive thrombosis with low platelet counts following the administration of the AstraZeneca vaccine.

The cases occurred seven to ten days after vaccination and involved women between 25 and 65 years old.

At the time of these incidents, a total of approximately 400,000 people in the country had been vaccinated with the AstraZeneca vaccine.

In addition, the possibility of this vaccine being associated with cases of thrombosis is being considered by Australia.

The country’s media reported that a 44-year-old man was admitted to a Melbourne hospital with possible thrombosis, a few days after receiving a dose of the AstraZeneca vaccine.

“Researchers have not yet confirmed any link to the vaccine, but investigations are ongoing,” an Australian expert told a news conference.

He even added that more details are expected tomorrow Saturday.

The Australian Therapeutic Agency has stated that the AstraZeneca vaccine is not associated with an increased overall risk of thrombosis.

With information from Reuters